These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35383273)

  • 1. Relationship of anti-SARS-CoV-2 IgG antibodies with Vitamin D and inflammatory markers in COVID-19 patients.
    Latifi-Pupovci H; Namani S; Pajaziti A; Ahmetaj-Shala B; Ajazaj L; Kotori A; Haxhibeqiri V; Gegaj V; Bunjaku G
    Sci Rep; 2022 Apr; 12(1):5699. PubMed ID: 35383273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti- SARS-CoV-2 IgG and IgM Levels in Iraqi General Population.
    Alobaidi AH; Mustafa HI; Salih AM; Alsamarai AM
    Antiinflamm Antiallergy Agents Med Chem; 2023; 22(2):113-129. PubMed ID: 37842890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of SARS-CoV-2 IgM and IgG Antibodies 3 Months after COVID-19 Onset in Moroccan Patients.
    Assaid N; Arich S; Charoute H; Akarid K; Anouar Sadat M; Maaroufi A; Ezzikouri S; Sarih M
    Am J Trop Med Hyg; 2023 Jan; 108(1):145-154. PubMed ID: 36509045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
    Hiki M; Tabe Y; Ai T; Matsue Y; Harada N; Sugimoto K; Matsushita Y; Matsushita M; Wakita M; Misawa S; Idei M; Miida T; Tamura N; Takahashi K; Naito T
    PLoS One; 2021; 16(4):e0249449. PubMed ID: 33822809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
    Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
    Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Free Light Chains (FLCs) Synthesis in Response to Exposure to SARS-CoV-2.
    Gudowska-Sawczuk M; Moniuszko-Malinowska A; Pączek S; Guziejko K; Chorąży M; Mroczko B
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.
    Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of plasma zinc levels with anti-SARS-CoV-2 IgG and IgA seropositivity in the general population: A case-control study.
    Equey A; Berger MM; Gonseth-Nusslé S; Augsburger M; Rezzi S; Hodgson ACC; Estoppey S; Pantaleo G; Pellaton C; Perrais M; Lenglet S; Rousson V; D'Acremont V; Bochud M
    Clin Nutr; 2023 Jun; 42(6):972-986. PubMed ID: 37130500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity.
    Wang J; Li D; Cameron A; Zhou Q; Wiltse A; Nayak J; Pecora ND; Zand MS
    J Infect Dis; 2022 Aug; 226(3):474-484. PubMed ID: 35091739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of Detection of Anti-SARS-CoV-2 IgG/IgM and SARS-CoV-2 RNA in Respiratory Tract Specimens in 48 COVID-19 Patients.
    Wu E; Zhang X; Zheng Y; Luo Z; Zhai W; Yin Z; Chen D; Wang Z; Zhai J; Han Y; Liu H; Li R; Wang Y; Feng Y; Shi G; Ma Y
    Clin Lab; 2021 Nov; 67(11):. PubMed ID: 34758225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-SARS-CoV-2 IgG levels in relation to disease severity of COVID-19.
    Yan X; Chen G; Jin Z; Zhang Z; Zhang B; He J; Yin S; Huang J; Fan M; Li Z; Chen F; Zeng Y; Han X; Zhu Y
    J Med Virol; 2022 Jan; 94(1):380-383. PubMed ID: 34403142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study.
    Amellal H; Assaid N; Charoute H; Akarid K; Maaroufi A; Ezzikouri S; Sarih M
    PLoS One; 2023; 18(7):e0288557. PubMed ID: 37437051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response.
    Takamatsu Y; Omata K; Shimizu Y; Kinoshita-Iwamoto N; Terada M; Suzuki T; Morioka S; Uemura Y; Ohmagari N; Maeda K; Mitsuya H
    Microbiol Spectr; 2022 Dec; 10(6):e0271622. PubMed ID: 36219096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients.
    Lei Q; Yu CZ; Li Y; Hou HY; Xu ZW; Yao ZJ; Zhang YD; Lai DY; Ndzouboukou JB; Zhang B; Chen H; Ouyang ZQ; Xue JB; Lin XS; Zheng YX; Wang XN; Jiang HW; Zhang HN; Qi H; Guo SJ; He MA; Sun ZY; Wang F; Tao SC; Fan XL
    J Adv Res; 2022 Feb; 36():133-145. PubMed ID: 35116173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Shedding of SARS-CoV-2 Virus in COVID-19 Patients and Neutralizing Antibody Level].
    Ayhancı T; Toptan H; Özer YE; Uzar S; Enül H; Adıay C; Sarac F; Dheir H; Köroğlu M; Hasöksüz M; Altındiş M
    Mikrobiyol Bul; 2022 Jul; 56(3):416-431. PubMed ID: 35960235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
    Al-Mughales JA; Al-Mughales TJ; Saadah OI
    Front Immunol; 2021; 12():705441. PubMed ID: 34539635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-SARS-CoV-2 IgG and Neutralizing Antibody Levels in Patients with Past COVID-19 Infection: A Longitudinal Study.
    Dinç HÖ; Demirci M; Özdemir YE; Sirekbasan S; Aktaş AN; Karaali R; Tuyji Tok Y; Özbey D; Akçin R; Gareayaghi N; Kuşkucu MA; Midilli K; Aygün G; Sarıbaş S; Kocazeybek B
    Balkan Med J; 2022 May; 39(3):172-177. PubMed ID: 35378574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response after COVID-19 vaccination in intravenous immunoglobulin-treated immune neuropathies.
    Svačina MKR; Meißner A; Schweitzer F; Ladwig A; Sprenger-Svačina A; Klein I; Wüstenberg H; Kohle F; Schneider C; Grether NB; Wunderlich G; Fink GR; Klein F; Di Cristanziano V; Lehmann HC
    Eur J Neurol; 2022 Nov; 29(11):3380-3388. PubMed ID: 35842740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10.
    Young MK; Kornmeier C; Carpenter RM; Natale NR; Sasson JM; Solga MD; Mathers AJ; Poulter MD; Qiang X; Petri WA
    medRxiv; 2020 Dec; ():. PubMed ID: 33330878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.